AKR1D1 (steroid 5-beta-reductase; 3-oxo-5-beta-steroid 4-dehydrogenase; Delta(4)-3-oxosteroid 5-beta-reductase; gene synonym SRD5B1) is a cytosolic aldo-keto reductase (EC 1.3.1.3) that catalyzes the NADPH-dependent stereospecific reduction of the C4-C5 (Delta4) double bond of 3-oxo-Delta4 steroids to the 5-beta configuration. This reduction creates the cis-fused (5-beta) A/B ring junction that is characteristic of bile acids. In bile-acid biosynthesis AKR1D1 reduces the CYP7A1/CYP8B1 pathway intermediates 7-alpha-hydroxy-4-cholesten-3-one and 7-alpha,12-alpha-dihydroxy-4-cholesten-3-one to their 5-beta-cholestan-3-one products, an obligatory step in the conversion of cholesterol into the primary bile acids cholic acid and chenodeoxycholic acid. The enzyme also 5-beta-reduces a broad range of C18-C27 3-oxo-Delta4 steroid hormones (including testosterone, progesterone, androstenedione, cortisol, cortisone, corticosterone and aldosterone), contributing to steroid hormone catabolism. AKR1D1 is highly expressed in liver. Loss-of-function variants cause congenital bile acid synthesis defect type 2 (CBAS2; AKR1D1 deficiency), a neonatal cholestatic liver disease with jaundice and hepatic failure.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0004032
aldose reductase (NADPH) activity
|
IBA
GO_REF:0000033 |
MODIFY |
Summary: Family-level phylogenetic (IBA) molecular-function call inherited from the aldo-keto reductase (AKR1) family. AKR1D1 is a steroid 5-beta-reductase, not an aldose reductase; it shares only ~50% sequence identity with human aldose reductase and does not have aldose reductase as its physiological function.
Reason: This is an over-general family term. The informative, experimentally supported molecular function of AKR1D1 is Delta4-3-oxosteroid 5beta-reductase activity (GO:0047787, EC 1.3.1.3). The IBA correctly places the protein in the AKR family but the specific activity should be used.
Propagation Review
Root cause:
TERM SCOPING PROBLEM
Failure modes:
GRANULARITY MISMATCH
FUNCTIONAL DIVERGENCE
Proposed replacements:
Delta4-3-oxosteroid 5beta-reductase activity
Supporting Evidence:
PMID:7508385
single delta 4-3-oxosteroid 5
file:human/AKR1D1/AKR1D1-uniprot.txt
Catalyzes the stereospecific NADPH-dependent reduction of the
|
|
GO:0005829
cytosol
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic inference that AKR1D1 acts in the cytosol, consistent with the family being soluble cytosolic aldo-keto reductases and with direct experimental localization of AKR1D1 itself.
Reason: Cytosolic localization is directly supported by experimental data (HPA IDA, PMID:7508385 IDA) and by the UniProt subcellular location. This is the core compartment where AKR1D1 acts.
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm
|
|
GO:0016229
steroid dehydrogenase activity
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: Phylogenetic (IBA) molecular-function call placing AKR1D1 as a steroid dehydrogenase/reductase. AKR1D1 acts on steroid substrates via an NADPH-dependent oxidoreductase mechanism, so this parent term is correct but less specific than the 5-beta-reductase activity.
Reason: Correct but general parent of the specific molecular function. Retained as a valid broader classification; the specific Delta4-3-oxosteroid 5beta-reductase activity (GO:0047787) is the core MF captured separately.
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
C4-C5 double bond of bile acid intermediates and steroid hormones
|
|
GO:0008209
androgen metabolic process
|
IBA
GO_REF:0000033 |
MARK AS OVER ANNOTATED |
Summary: Phylogenetic inference of involvement in androgen metabolism. AKR1D1 can 5-beta-reduce androgens such as testosterone and androstenedione in vitro, but the human enzyme has a considerably narrower steroid-hormone activity than its rodent orthologs and its physiological role is dominated by bile acid biosynthesis.
Reason: Androgen metabolism is a peripheral in vitro activity for the human enzyme, which the original characterization notes is much narrower than the rat enzyme and more important for bile acid biosynthesis. Not a core process.
Propagation Review
Root cause:
NO FAILURE NON CORE
Failure modes:
FUNCTIONAL DIVERGENCE
Supporting Evidence:
PMID:7508385
more important for bile acid biosynthesis than for metabolism
|
|
GO:0047086
ketosteroid monooxygenase activity
|
IBA
GO_REF:0000033 |
MARK AS OVER ANNOTATED |
Summary: Phylogenetic (IBA) family term for a ketosteroid monooxygenase activity. AKR1D1 is an NADPH-dependent reductase (it reduces a C=C double bond), not a monooxygenase, and no oxygen-incorporating monooxygenase activity is described for it.
Reason: Mechanistically inconsistent with AKR1D1, which is a 5-beta-reductase. Monooxygenase activity is an over-propagated family term not supported for this protein.
Propagation Review
Root cause:
PROPAGATION BAD
Failure modes:
FUNCTIONAL DIVERGENCE
GRANULARITY MISMATCH
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
Catalyzes the stereospecific NADPH-dependent reduction of the
|
|
GO:0005737
cytoplasm
|
IEA
GO_REF:0000044 |
KEEP AS NON CORE |
Summary: Electronic annotation of cytoplasmic localization from the UniProt Subcellular Location mapping, consistent with AKR1D1 being a soluble cytosolic enzyme.
Reason: Correct but broader than cytosol; the more precise cytosol term (GO:0005829) is the core compartment and is separately supported experimentally.
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm
|
|
GO:0006699
bile acid biosynthetic process
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: InterPro2GO electronic annotation to bile acid biosynthetic process via the AKR1D1-specific InterPro entry (IPR044483). This is the central biological process for AKR1D1.
Reason: Bile acid biosynthesis is the core physiological role of AKR1D1, supported by experimental (IDA PMID:7508385), Reactome (TAS) and InterPro (IEA) evidence.
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
This cis-configuration is crucial for bile acid biosynthesis
|
|
GO:0008106
alcohol dehydrogenase (NADP+) activity
|
IEA
GO_REF:0000117 |
MARK AS OVER ANNOTATED |
Summary: ARBA machine-learning electronic annotation to alcohol dehydrogenase (NADP+) activity. AKR1D1 catalyzes reduction of a C4-C5 carbon-carbon double bond of 3-oxo-Delta4 steroids, not oxidation/reduction of an alcohol/carbonyl; this generic AKR mechanistic label does not capture the double-bond reductase function.
Reason: Less informative and mechanistically imprecise for AKR1D1. The physiological reaction is NADPH-dependent Delta4 double-bond reduction (GO:0047787, EC 1.3.1.3), not alcohol dehydrogenase activity.
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
C4-C5 double bond of bile acid intermediates and steroid hormones
|
|
GO:0008202
steroid metabolic process
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Electronic annotation to the general steroid metabolic process, consistent with AKR1D1 acting on steroid substrates (bile acid intermediates and steroid hormones).
Reason: Correct broad biological-process classification. AKR1D1 metabolizes steroid substrates as part of bile acid biosynthesis and steroid hormone metabolism.
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
C4-C5 double bond of bile acid intermediates and steroid hormones
|
|
GO:0016491
oxidoreductase activity
|
IEA
GO_REF:0000002 |
MODIFY |
Summary: InterPro2GO electronic annotation to the root oxidoreductase activity term from AKR family signatures. AKR1D1 is an NADPH-dependent oxidoreductase, but this is the least specific possible MF.
Reason: Too general. Should be replaced by the specific Delta4-3-oxosteroid 5beta-reductase activity (GO:0047787).
Proposed replacements:
Delta4-3-oxosteroid 5beta-reductase activity
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
Catalyzes the stereospecific NADPH-dependent reduction of the
|
|
GO:0032787
monocarboxylic acid metabolic process
|
IEA
GO_REF:0000117 |
MARK AS OVER ANNOTATED |
Summary: ARBA electronic annotation to monocarboxylic acid metabolic process, presumably inferred because bile acids are monocarboxylic acids. AKR1D1 acts on steroid ring intermediates upstream of the fully formed bile acid carboxylate and does not itself metabolize the carboxylic acid moiety.
Reason: Over-general/indirect. AKR1D1's function is steroid Delta4 double-bond reduction; the monocarboxylic acid framing is a downstream consequence, not the enzyme's activity. Bile acid biosynthetic process (GO:0006699) captures the role more precisely.
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
This cis-configuration is crucial for bile acid biosynthesis
|
|
GO:0042445
hormone metabolic process
|
IEA
GO_REF:0000117 |
MARK AS OVER ANNOTATED |
Summary: ARBA electronic annotation to hormone metabolic process, reflecting that AKR1D1 can 5-beta-reduce steroid hormones. For the human enzyme this is a secondary activity relative to bile acid biosynthesis.
Reason: Peripheral for the human enzyme, whose steroid-hormone activity is narrower than the rodent ortholog and whose dominant role is bile acid biosynthesis.
Supporting Evidence:
PMID:7508385
more important for bile acid biosynthesis than for metabolism
|
|
GO:0047787
Delta4-3-oxosteroid 5beta-reductase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Automated (EC/Rhea-based) annotation to the specific molecular function of AKR1D1: Delta4-3-oxosteroid 5beta-reductase (EC 1.3.1.3). This is the core, informative molecular function, extensively supported experimentally by enzyme characterization and crystallography.
Reason: This is the defining molecular function of AKR1D1, matching EC 1.3.1.3 and the multiple curated Rhea catalytic-activity reactions in UniProt (reduction of 3-oxo-Delta4 steroids to the 5-beta configuration). Core function.
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
Catalyzes the stereospecific NADPH-dependent reduction of the
PMID:7508385
single delta 4-3-oxosteroid 5
|
|
GO:0072582
17-beta-hydroxysteroid dehydrogenase (NADP+) activity
|
IEA
GO_REF:0000116 |
MARK AS OVER ANNOTATED |
Summary: Rhea-mapped electronic annotation (RHEA:53484, androst-4-ene-3,11,17-trione to 17beta-hydroxyandrost-4-ene-3,11-dione) inferred as a 17-beta-hydroxysteroid dehydrogenase activity. This reflects one in vitro reaction; AKR1D1's characterized physiological activity is Delta4 5-beta double-bond reduction, not 17-beta-HSD chemistry.
Reason: An automated Rhea mapping of a single side reaction; not the core or informative molecular function. The 5-beta-reductase activity (GO:0047787) is the physiologically relevant term.
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
C4-C5 double bond of bile acid intermediates and steroid hormones
|
|
GO:0005515
protein binding
|
IPI
PMID:28514442 Architecture of the human interactome defines protein commun... |
MARK AS OVER ANNOTATED |
Summary: Protein binding annotation from a high-throughput BioPlex 2.0 AP-MS interactome screen (interactor AKR1C1, UniProt Q04828). This is a proteome-scale physical interaction, not an informative molecular function.
Reason: Bare "protein binding" carries no functional information about AKR1D1 and is derived from a large-scale interactome dataset. Per curation guidelines this uninformative term is marked as over-annotated rather than retained as a function.
Supporting Evidence:
PMID:28514442
affinity purification-mass spectrometry methodology to elucidate protein
|
|
GO:0005515
protein binding
|
IPI
PMID:33961781 Dual proteome-scale networks reveal cell-specific remodeling... |
MARK AS OVER ANNOTATED |
Summary: Protein binding annotation from the BioPlex 3.0 proteome-scale AP-MS interactome (interactor AKR1C1, UniProt Q04828). A high-throughput physical interaction rather than an informative molecular function.
Reason: Uninformative bare "protein binding" from a large-scale interactome dataset; marked as over-annotated per curation guidelines.
Supporting Evidence:
PMID:33961781
The first, BioPlex 3.0, results from affinity purification
|
|
GO:0006699
bile acid biosynthetic process
|
TAS
Reactome:R-HSA-193368 |
ACCEPT |
Summary: Reactome traceable-author annotation placing AKR1D1 in the bile acid and bile salt synthesis pathway via 7alpha-hydroxycholesterol. Core process.
Reason: Bile acid biosynthesis is the central role of AKR1D1, corroborated by experimental and InterPro evidence.
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
This cis-configuration is crucial for bile acid biosynthesis
|
|
GO:0006699
bile acid biosynthetic process
|
TAS
Reactome:R-HSA-193775 |
ACCEPT |
Summary: Reactome traceable-author annotation placing AKR1D1 in bile acid/bile salt synthesis via 24-hydroxycholesterol. Core process.
Reason: Consistent with the core bile acid biosynthetic role of AKR1D1.
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
This cis-configuration is crucial for bile acid biosynthesis
|
|
GO:0006699
bile acid biosynthetic process
|
TAS
Reactome:R-HSA-193807 |
ACCEPT |
Summary: Reactome traceable-author annotation placing AKR1D1 in bile acid/bile salt synthesis via 27-hydroxycholesterol. Core process.
Reason: Consistent with the core bile acid biosynthetic role of AKR1D1.
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
This cis-configuration is crucial for bile acid biosynthesis
|
|
GO:0008106
alcohol dehydrogenase (NADP+) activity
|
TAS
Reactome:R-HSA-192033 |
MARK AS OVER ANNOTATED |
Summary: Reactome mechanistic molecular-function label attached to the AKR1D1-catalyzed reduction of 4-cholesten-7alpha-ol-3-one. The reaction reduces the steroid C4-C5 double bond; "alcohol dehydrogenase (NADP+)" is a generic AKR label that is less informative than the 5-beta-reductase activity.
Reason: Imprecise MF for AKR1D1. The physiologically relevant activity is Delta4-3-oxosteroid 5beta-reductase (GO:0047787, EC 1.3.1.3).
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
C4-C5 double bond of bile acid intermediates and steroid hormones
|
|
GO:0008106
alcohol dehydrogenase (NADP+) activity
|
TAS
Reactome:R-HSA-192067 |
MARK AS OVER ANNOTATED |
Summary: Reactome mechanistic MF label for the AKR1D1-catalyzed reduction of 4-cholesten-7alpha,12alpha-diol-3-one; generic AKR label less informative than the 5-beta-reductase activity.
Reason: Imprecise MF; the physiological activity is Delta4-3-oxosteroid 5beta-reductase (GO:0047787).
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
C4-C5 double bond of bile acid intermediates and steroid hormones
|
|
GO:0008106
alcohol dehydrogenase (NADP+) activity
|
TAS
Reactome:R-HSA-193746 |
MARK AS OVER ANNOTATED |
Summary: Reactome mechanistic MF label for the AKR1D1-catalyzed reduction of 4-cholesten-7alpha,24(S)-diol-3-one; generic AKR label less informative than the 5-beta-reductase activity.
Reason: Imprecise MF; the physiological activity is Delta4-3-oxosteroid 5beta-reductase (GO:0047787).
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
C4-C5 double bond of bile acid intermediates and steroid hormones
|
|
GO:0008106
alcohol dehydrogenase (NADP+) activity
|
TAS
Reactome:R-HSA-193755 |
MARK AS OVER ANNOTATED |
Summary: Reactome mechanistic MF label for an AKR1D1-catalyzed 5-beta-reduction step in bile acid synthesis; generic AKR label less informative than the 5-beta-reductase activity.
Reason: Imprecise MF; the physiological activity is Delta4-3-oxosteroid 5beta-reductase (GO:0047787).
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
C4-C5 double bond of bile acid intermediates and steroid hormones
|
|
GO:0008106
alcohol dehydrogenase (NADP+) activity
|
TAS
Reactome:R-HSA-193821 |
MARK AS OVER ANNOTATED |
Summary: Reactome mechanistic MF label for the AKR1D1-catalyzed reduction of 4-cholesten-7alpha,12alpha,27-triol-3-one; generic AKR label less informative than the 5-beta-reductase activity.
Reason: Imprecise MF; the physiological activity is Delta4-3-oxosteroid 5beta-reductase (GO:0047787).
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
C4-C5 double bond of bile acid intermediates and steroid hormones
|
|
GO:0008106
alcohol dehydrogenase (NADP+) activity
|
TAS
Reactome:R-HSA-193824 |
MARK AS OVER ANNOTATED |
Summary: Reactome mechanistic MF label for the AKR1D1-catalyzed reduction of 4-cholesten-7alpha,27-diol-3-one; generic AKR label less informative than the 5-beta-reductase activity.
Reason: Imprecise MF; the physiological activity is Delta4-3-oxosteroid 5beta-reductase (GO:0047787).
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
C4-C5 double bond of bile acid intermediates and steroid hormones
|
|
GO:0005829
cytosol
|
IDA
GO_REF:0000052 |
ACCEPT |
Summary: Direct assay (Human Protein Atlas immunofluorescence) localizing AKR1D1 to the cytosol. Consistent with the soluble cytosolic nature of the enzyme.
Reason: Cytosol is the core compartment for AKR1D1, supported by direct assay and by UniProt.
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm
|
|
GO:0005737
cytoplasm
|
EXP
PMID:7508385 Cloning and expression of cDNA of human delta 4-3-oxosteroid... |
KEEP AS NON CORE |
Summary: Experimental localization of AKR1D1 to the cytoplasm from the original cloning/expression study of the human enzyme.
Reason: Correct but broader than cytosol; retained as non-core because the more precise cytosol term is the core compartment.
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-192033 |
ACCEPT |
Summary: Reactome traceable-author localization of AKR1D1 to the cytosol for the bile acid synthesis reduction reactions.
Reason: Consistent with the core cytosolic localization of AKR1D1.
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-192067 |
ACCEPT |
Summary: Reactome traceable-author localization of AKR1D1 to the cytosol.
Reason: Consistent with the core cytosolic localization of AKR1D1.
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-193746 |
ACCEPT |
Summary: Reactome traceable-author localization of AKR1D1 to the cytosol.
Reason: Consistent with the core cytosolic localization of AKR1D1.
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-193755 |
ACCEPT |
Summary: Reactome traceable-author localization of AKR1D1 to the cytosol.
Reason: Consistent with the core cytosolic localization of AKR1D1.
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-193821 |
ACCEPT |
Summary: Reactome traceable-author localization of AKR1D1 to the cytosol.
Reason: Consistent with the core cytosolic localization of AKR1D1.
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-193824 |
ACCEPT |
Summary: Reactome traceable-author localization of AKR1D1 to the cytosol.
Reason: Consistent with the core cytosolic localization of AKR1D1.
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm
|
|
GO:0005496
steroid binding
|
TAS
PMID:7508385 Cloning and expression of cDNA of human delta 4-3-oxosteroid... |
KEEP AS NON CORE |
Summary: Steroid binding molecular function, consistent with AKR1D1 binding its 3-oxo-Delta4 steroid substrates in the active site (seen in multiple substrate co-crystal structures). This binding is part of, and subordinate to, the catalytic 5-beta-reductase activity.
Reason: Steroid binding is a genuine molecular property (substrate binding) but is a component of the catalytic 5-beta-reductase function rather than an independent core function.
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
C4-C5 double bond of bile acid intermediates and steroid hormones
|
|
GO:0005829
cytosol
|
IDA
PMID:7508385 Cloning and expression of cDNA of human delta 4-3-oxosteroid... |
ACCEPT |
Summary: Direct experimental localization of the human enzyme to the cytosol in the original cloning/expression study.
Reason: Core cytosolic localization, directly supported.
Supporting Evidence:
file:human/AKR1D1/AKR1D1-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm
|
|
GO:0006699
bile acid biosynthetic process
|
IDA
PMID:7508385 Cloning and expression of cDNA of human delta 4-3-oxosteroid... |
ACCEPT |
Summary: Direct experimental demonstration that the expressed human enzyme has high 5-beta-reductase activity toward the bile acid intermediates 7alpha-hydroxy- and 7alpha,12alpha-dihydroxy-4-cholesten-3-one, and is more important for bile acid biosynthesis than for steroid hormone metabolism. This is the core process.
Reason: Directly demonstrated core biological process; the expressed enzyme reduces the key bile acid biosynthetic intermediates.
Supporting Evidence:
PMID:7508385
more important for bile acid biosynthesis than for metabolism
|
|
GO:0006707
cholesterol catabolic process
|
IDA
PMID:7508385 Cloning and expression of cDNA of human delta 4-3-oxosteroid... |
MARK AS OVER ANNOTATED |
Summary: Bile acid biosynthesis is the major route of cholesterol catabolism, so AKR1D1 is generically associated with cholesterol catabolism. However AKR1D1 does not act on cholesterol itself; it reduces 3-oxo-Delta4 ring intermediates several steps downstream.
Reason: Indirect/downstream framing. AKR1D1's direct substrates are 3-oxo-Delta4 steroid intermediates, not cholesterol. Bile acid biosynthetic process (GO:0006699) is the precise term for its role.
Supporting Evidence:
PMID:7508385
more important for bile acid biosynthesis than for metabolism
|
|
GO:0007586
digestion
|
IDA
PMID:7508385 Cloning and expression of cDNA of human delta 4-3-oxosteroid... |
MARK AS OVER ANNOTATED |
Summary: Bile acids produced downstream of AKR1D1 aid dietary lipid digestion, so the enzyme is indirectly linked to digestion. This is a distal physiological consequence, not a direct function of AKR1D1.
Reason: Too indirect. AKR1D1 acts in hepatic bile acid biosynthesis; digestion is a downstream consequence of bile acids, not an activity of the enzyme.
Supporting Evidence:
PMID:7508385
more important for bile acid biosynthesis than for metabolism
|
|
GO:0008207
C21-steroid hormone metabolic process
|
IDA
PMID:7508385 Cloning and expression of cDNA of human delta 4-3-oxosteroid... |
MARK AS OVER ANNOTATED |
Summary: AKR1D1 can 5-beta-reduce C21 steroid hormones (e.g. cortisol) in vitro. In the original characterization this activity was small relative to the bile acid intermediate activity, and the human enzyme is narrower than the rat enzyme.
Reason: A secondary in vitro activity for the human enzyme, subordinate to its core bile acid biosynthetic role.
Supporting Evidence:
PMID:7508385
small but significant 5 beta-reduction
|
|
GO:0008209
androgen metabolic process
|
IDA
PMID:7508385 Cloning and expression of cDNA of human delta 4-3-oxosteroid... |
MARK AS OVER ANNOTATED |
Summary: AKR1D1 can 5-beta-reduce androgens (e.g. testosterone) in vitro, but in the original characterization no activity was seen toward androstenedione and the human enzyme's steroid-hormone activity is narrower than the rat enzyme and secondary to bile acid biosynthesis.
Reason: Peripheral in vitro activity for the human enzyme; not a core process.
Supporting Evidence:
PMID:7508385
more important for bile acid biosynthesis than for metabolism
|
|
GO:0006699
bile acid biosynthetic process
|
IDA
PMID:7508385 Cloning and expression of cDNA of human delta 4-3-oxosteroid... |
ACCEPT |
Summary: Direct experimental annotation (MGI) that AKR1D1 acts upstream of or within bile acid biosynthesis, based on the demonstrated reduction of bile acid intermediates. Core process.
Reason: Core biological process directly supported by the enzyme's demonstrated reduction of bile acid biosynthetic intermediates.
Supporting Evidence:
PMID:7508385
more important for bile acid biosynthesis than for metabolism
|
id: P51857
gene_symbol: AKR1D1
product_type: PROTEIN
status: INITIALIZED
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
AKR1D1 (steroid 5-beta-reductase; 3-oxo-5-beta-steroid 4-dehydrogenase;
Delta(4)-3-oxosteroid 5-beta-reductase; gene synonym SRD5B1) is a cytosolic
aldo-keto reductase (EC 1.3.1.3) that catalyzes the NADPH-dependent
stereospecific reduction of the C4-C5 (Delta4) double bond of 3-oxo-Delta4
steroids to the 5-beta configuration. This reduction creates the cis-fused
(5-beta) A/B ring junction that is characteristic of bile acids. In bile-acid
biosynthesis AKR1D1 reduces the CYP7A1/CYP8B1 pathway intermediates
7-alpha-hydroxy-4-cholesten-3-one and 7-alpha,12-alpha-dihydroxy-4-cholesten-3-one
to their 5-beta-cholestan-3-one products, an obligatory step in the conversion
of cholesterol into the primary bile acids cholic acid and chenodeoxycholic
acid. The enzyme also 5-beta-reduces a broad range of C18-C27 3-oxo-Delta4
steroid hormones (including testosterone, progesterone, androstenedione,
cortisol, cortisone, corticosterone and aldosterone), contributing to steroid
hormone catabolism. AKR1D1 is highly expressed in liver. Loss-of-function
variants cause congenital bile acid synthesis defect type 2 (CBAS2; AKR1D1
deficiency), a neonatal cholestatic liver disease with jaundice and hepatic
failure.
alternative_products:
- name: '1'
id: P51857-1
- name: '2'
id: P51857-2
sequence_note: VSP_042901
- name: '3'
id: P51857-3
sequence_note: VSP_042913
existing_annotations:
- term:
id: GO:0004032
label: aldose reductase (NADPH) activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: >-
Family-level phylogenetic (IBA) molecular-function call inherited from the
aldo-keto reductase (AKR1) family. AKR1D1 is a steroid 5-beta-reductase,
not an aldose reductase; it shares only ~50% sequence identity with human
aldose reductase and does not have aldose reductase as its physiological
function.
action: MODIFY
reason: >-
This is an over-general family term. The informative, experimentally
supported molecular function of AKR1D1 is Delta4-3-oxosteroid
5beta-reductase activity (GO:0047787, EC 1.3.1.3). The IBA correctly places
the protein in the AKR family but the specific activity should be used.
proposed_replacement_terms:
- id: GO:0047787
label: Delta4-3-oxosteroid 5beta-reductase activity
propagation_review:
root_cause: TERM_SCOPING_PROBLEM
failure_modes:
- GRANULARITY_MISMATCH
- FUNCTIONAL_DIVERGENCE
supported_by:
- reference_id: PMID:7508385
supporting_text: >-
single delta 4-3-oxosteroid 5
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
Catalyzes the stereospecific NADPH-dependent reduction of the
- term:
id: GO:0005829
label: cytosol
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: is_active_in
review:
summary: >-
Phylogenetic inference that AKR1D1 acts in the cytosol, consistent with the
family being soluble cytosolic aldo-keto reductases and with direct
experimental localization of AKR1D1 itself.
action: ACCEPT
reason: >-
Cytosolic localization is directly supported by experimental data (HPA IDA,
PMID:7508385 IDA) and by the UniProt subcellular location. This is the core
compartment where AKR1D1 acts.
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
SUBCELLULAR LOCATION: Cytoplasm
- term:
id: GO:0016229
label: steroid dehydrogenase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: >-
Phylogenetic (IBA) molecular-function call placing AKR1D1 as a steroid
dehydrogenase/reductase. AKR1D1 acts on steroid substrates via an
NADPH-dependent oxidoreductase mechanism, so this parent term is correct
but less specific than the 5-beta-reductase activity.
action: KEEP_AS_NON_CORE
reason: >-
Correct but general parent of the specific molecular function. Retained as
a valid broader classification; the specific Delta4-3-oxosteroid
5beta-reductase activity (GO:0047787) is the core MF captured separately.
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
C4-C5 double bond of bile acid intermediates and steroid hormones
- term:
id: GO:0008209
label: androgen metabolic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
Phylogenetic inference of involvement in androgen metabolism. AKR1D1 can
5-beta-reduce androgens such as testosterone and androstenedione in vitro,
but the human enzyme has a considerably narrower steroid-hormone activity
than its rodent orthologs and its physiological role is dominated by bile
acid biosynthesis.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Androgen metabolism is a peripheral in vitro activity for the human enzyme,
which the original characterization notes is much narrower than the rat
enzyme and more important for bile acid biosynthesis. Not a core process.
propagation_review:
root_cause: NO_FAILURE_NON_CORE
failure_modes:
- FUNCTIONAL_DIVERGENCE
supported_by:
- reference_id: PMID:7508385
supporting_text: >-
more important for bile acid biosynthesis than for metabolism
- term:
id: GO:0047086
label: ketosteroid monooxygenase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: >-
Phylogenetic (IBA) family term for a ketosteroid monooxygenase activity.
AKR1D1 is an NADPH-dependent reductase (it reduces a C=C double bond), not a
monooxygenase, and no oxygen-incorporating monooxygenase activity is
described for it.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Mechanistically inconsistent with AKR1D1, which is a 5-beta-reductase.
Monooxygenase activity is an over-propagated family term not supported for
this protein.
propagation_review:
root_cause: PROPAGATION_BAD
failure_modes:
- FUNCTIONAL_DIVERGENCE
- GRANULARITY_MISMATCH
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
Catalyzes the stereospecific NADPH-dependent reduction of the
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IEA
original_reference_id: GO_REF:0000044
qualifier: located_in
review:
summary: >-
Electronic annotation of cytoplasmic localization from the UniProt
Subcellular Location mapping, consistent with AKR1D1 being a soluble
cytosolic enzyme.
action: KEEP_AS_NON_CORE
reason: >-
Correct but broader than cytosol; the more precise cytosol term (GO:0005829)
is the core compartment and is separately supported experimentally.
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
SUBCELLULAR LOCATION: Cytoplasm
- term:
id: GO:0006699
label: bile acid biosynthetic process
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: involved_in
review:
summary: >-
InterPro2GO electronic annotation to bile acid biosynthetic process via the
AKR1D1-specific InterPro entry (IPR044483). This is the central biological
process for AKR1D1.
action: ACCEPT
reason: >-
Bile acid biosynthesis is the core physiological role of AKR1D1, supported
by experimental (IDA PMID:7508385), Reactome (TAS) and InterPro (IEA)
evidence.
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
This cis-configuration is crucial for bile acid biosynthesis
- term:
id: GO:0008106
label: alcohol dehydrogenase (NADP+) activity
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: enables
review:
summary: >-
ARBA machine-learning electronic annotation to alcohol dehydrogenase
(NADP+) activity. AKR1D1 catalyzes reduction of a C4-C5 carbon-carbon
double bond of 3-oxo-Delta4 steroids, not oxidation/reduction of an
alcohol/carbonyl; this generic AKR mechanistic label does not capture the
double-bond reductase function.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Less informative and mechanistically imprecise for AKR1D1. The physiological
reaction is NADPH-dependent Delta4 double-bond reduction (GO:0047787,
EC 1.3.1.3), not alcohol dehydrogenase activity.
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
C4-C5 double bond of bile acid intermediates and steroid hormones
- term:
id: GO:0008202
label: steroid metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: involved_in
review:
summary: >-
Electronic annotation to the general steroid metabolic process, consistent
with AKR1D1 acting on steroid substrates (bile acid intermediates and
steroid hormones).
action: ACCEPT
reason: >-
Correct broad biological-process classification. AKR1D1 metabolizes steroid
substrates as part of bile acid biosynthesis and steroid hormone
metabolism.
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
C4-C5 double bond of bile acid intermediates and steroid hormones
- term:
id: GO:0016491
label: oxidoreductase activity
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: >-
InterPro2GO electronic annotation to the root oxidoreductase activity term
from AKR family signatures. AKR1D1 is an NADPH-dependent oxidoreductase, but
this is the least specific possible MF.
action: MODIFY
reason: >-
Too general. Should be replaced by the specific Delta4-3-oxosteroid
5beta-reductase activity (GO:0047787).
proposed_replacement_terms:
- id: GO:0047787
label: Delta4-3-oxosteroid 5beta-reductase activity
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
Catalyzes the stereospecific NADPH-dependent reduction of the
- term:
id: GO:0032787
label: monocarboxylic acid metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: involved_in
review:
summary: >-
ARBA electronic annotation to monocarboxylic acid metabolic process,
presumably inferred because bile acids are monocarboxylic acids. AKR1D1
acts on steroid ring intermediates upstream of the fully formed bile acid
carboxylate and does not itself metabolize the carboxylic acid moiety.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Over-general/indirect. AKR1D1's function is steroid Delta4 double-bond
reduction; the monocarboxylic acid framing is a downstream consequence, not
the enzyme's activity. Bile acid biosynthetic process (GO:0006699) captures
the role more precisely.
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
This cis-configuration is crucial for bile acid biosynthesis
- term:
id: GO:0042445
label: hormone metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: involved_in
review:
summary: >-
ARBA electronic annotation to hormone metabolic process, reflecting that
AKR1D1 can 5-beta-reduce steroid hormones. For the human enzyme this is a
secondary activity relative to bile acid biosynthesis.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Peripheral for the human enzyme, whose steroid-hormone activity is narrower
than the rodent ortholog and whose dominant role is bile acid biosynthesis.
supported_by:
- reference_id: PMID:7508385
supporting_text: >-
more important for bile acid biosynthesis than for metabolism
- term:
id: GO:0047787
label: Delta4-3-oxosteroid 5beta-reductase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Automated (EC/Rhea-based) annotation to the specific molecular function of
AKR1D1: Delta4-3-oxosteroid 5beta-reductase (EC 1.3.1.3). This is the core,
informative molecular function, extensively supported experimentally by
enzyme characterization and crystallography.
action: ACCEPT
reason: >-
This is the defining molecular function of AKR1D1, matching EC 1.3.1.3 and
the multiple curated Rhea catalytic-activity reactions in UniProt (reduction
of 3-oxo-Delta4 steroids to the 5-beta configuration). Core function.
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
Catalyzes the stereospecific NADPH-dependent reduction of the
- reference_id: PMID:7508385
supporting_text: >-
single delta 4-3-oxosteroid 5
- term:
id: GO:0072582
label: 17-beta-hydroxysteroid dehydrogenase (NADP+) activity
evidence_type: IEA
original_reference_id: GO_REF:0000116
qualifier: enables
review:
summary: >-
Rhea-mapped electronic annotation (RHEA:53484, androst-4-ene-3,11,17-trione
to 17beta-hydroxyandrost-4-ene-3,11-dione) inferred as a
17-beta-hydroxysteroid dehydrogenase activity. This reflects one in vitro
reaction; AKR1D1's characterized physiological activity is Delta4 5-beta
double-bond reduction, not 17-beta-HSD chemistry.
action: MARK_AS_OVER_ANNOTATED
reason: >-
An automated Rhea mapping of a single side reaction; not the core or
informative molecular function. The 5-beta-reductase activity (GO:0047787)
is the physiologically relevant term.
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
C4-C5 double bond of bile acid intermediates and steroid hormones
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:28514442
qualifier: enables
review:
summary: >-
Protein binding annotation from a high-throughput BioPlex 2.0 AP-MS
interactome screen (interactor AKR1C1, UniProt Q04828). This is a
proteome-scale physical interaction, not an informative molecular function.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Bare "protein binding" carries no functional information about AKR1D1 and is
derived from a large-scale interactome dataset. Per curation guidelines this
uninformative term is marked as over-annotated rather than retained as a
function.
supported_by:
- reference_id: PMID:28514442
supporting_text: >-
affinity purification-mass spectrometry methodology to elucidate protein
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:33961781
qualifier: enables
review:
summary: >-
Protein binding annotation from the BioPlex 3.0 proteome-scale AP-MS
interactome (interactor AKR1C1, UniProt Q04828). A high-throughput physical
interaction rather than an informative molecular function.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Uninformative bare "protein binding" from a large-scale interactome dataset;
marked as over-annotated per curation guidelines.
supported_by:
- reference_id: PMID:33961781
supporting_text: >-
The first, BioPlex 3.0, results from affinity purification
- term:
id: GO:0006699
label: bile acid biosynthetic process
evidence_type: TAS
original_reference_id: Reactome:R-HSA-193368
qualifier: involved_in
review:
summary: >-
Reactome traceable-author annotation placing AKR1D1 in the bile acid and
bile salt synthesis pathway via 7alpha-hydroxycholesterol. Core process.
action: ACCEPT
reason: >-
Bile acid biosynthesis is the central role of AKR1D1, corroborated by
experimental and InterPro evidence.
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
This cis-configuration is crucial for bile acid biosynthesis
- term:
id: GO:0006699
label: bile acid biosynthetic process
evidence_type: TAS
original_reference_id: Reactome:R-HSA-193775
qualifier: involved_in
review:
summary: >-
Reactome traceable-author annotation placing AKR1D1 in bile acid/bile salt
synthesis via 24-hydroxycholesterol. Core process.
action: ACCEPT
reason: >-
Consistent with the core bile acid biosynthetic role of AKR1D1.
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
This cis-configuration is crucial for bile acid biosynthesis
- term:
id: GO:0006699
label: bile acid biosynthetic process
evidence_type: TAS
original_reference_id: Reactome:R-HSA-193807
qualifier: involved_in
review:
summary: >-
Reactome traceable-author annotation placing AKR1D1 in bile acid/bile salt
synthesis via 27-hydroxycholesterol. Core process.
action: ACCEPT
reason: >-
Consistent with the core bile acid biosynthetic role of AKR1D1.
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
This cis-configuration is crucial for bile acid biosynthesis
- term:
id: GO:0008106
label: alcohol dehydrogenase (NADP+) activity
evidence_type: TAS
original_reference_id: Reactome:R-HSA-192033
qualifier: enables
review:
summary: >-
Reactome mechanistic molecular-function label attached to the AKR1D1-catalyzed
reduction of 4-cholesten-7alpha-ol-3-one. The reaction reduces the steroid
C4-C5 double bond; "alcohol dehydrogenase (NADP+)" is a generic AKR label
that is less informative than the 5-beta-reductase activity.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Imprecise MF for AKR1D1. The physiologically relevant activity is
Delta4-3-oxosteroid 5beta-reductase (GO:0047787, EC 1.3.1.3).
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
C4-C5 double bond of bile acid intermediates and steroid hormones
- term:
id: GO:0008106
label: alcohol dehydrogenase (NADP+) activity
evidence_type: TAS
original_reference_id: Reactome:R-HSA-192067
qualifier: enables
review:
summary: >-
Reactome mechanistic MF label for the AKR1D1-catalyzed reduction of
4-cholesten-7alpha,12alpha-diol-3-one; generic AKR label less informative
than the 5-beta-reductase activity.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Imprecise MF; the physiological activity is Delta4-3-oxosteroid
5beta-reductase (GO:0047787).
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
C4-C5 double bond of bile acid intermediates and steroid hormones
- term:
id: GO:0008106
label: alcohol dehydrogenase (NADP+) activity
evidence_type: TAS
original_reference_id: Reactome:R-HSA-193746
qualifier: enables
review:
summary: >-
Reactome mechanistic MF label for the AKR1D1-catalyzed reduction of
4-cholesten-7alpha,24(S)-diol-3-one; generic AKR label less informative than
the 5-beta-reductase activity.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Imprecise MF; the physiological activity is Delta4-3-oxosteroid
5beta-reductase (GO:0047787).
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
C4-C5 double bond of bile acid intermediates and steroid hormones
- term:
id: GO:0008106
label: alcohol dehydrogenase (NADP+) activity
evidence_type: TAS
original_reference_id: Reactome:R-HSA-193755
qualifier: enables
review:
summary: >-
Reactome mechanistic MF label for an AKR1D1-catalyzed 5-beta-reduction step
in bile acid synthesis; generic AKR label less informative than the
5-beta-reductase activity.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Imprecise MF; the physiological activity is Delta4-3-oxosteroid
5beta-reductase (GO:0047787).
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
C4-C5 double bond of bile acid intermediates and steroid hormones
- term:
id: GO:0008106
label: alcohol dehydrogenase (NADP+) activity
evidence_type: TAS
original_reference_id: Reactome:R-HSA-193821
qualifier: enables
review:
summary: >-
Reactome mechanistic MF label for the AKR1D1-catalyzed reduction of
4-cholesten-7alpha,12alpha,27-triol-3-one; generic AKR label less
informative than the 5-beta-reductase activity.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Imprecise MF; the physiological activity is Delta4-3-oxosteroid
5beta-reductase (GO:0047787).
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
C4-C5 double bond of bile acid intermediates and steroid hormones
- term:
id: GO:0008106
label: alcohol dehydrogenase (NADP+) activity
evidence_type: TAS
original_reference_id: Reactome:R-HSA-193824
qualifier: enables
review:
summary: >-
Reactome mechanistic MF label for the AKR1D1-catalyzed reduction of
4-cholesten-7alpha,27-diol-3-one; generic AKR label less informative than
the 5-beta-reductase activity.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Imprecise MF; the physiological activity is Delta4-3-oxosteroid
5beta-reductase (GO:0047787).
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
C4-C5 double bond of bile acid intermediates and steroid hormones
- term:
id: GO:0005829
label: cytosol
evidence_type: IDA
original_reference_id: GO_REF:0000052
qualifier: located_in
review:
summary: >-
Direct assay (Human Protein Atlas immunofluorescence) localizing AKR1D1 to
the cytosol. Consistent with the soluble cytosolic nature of the enzyme.
action: ACCEPT
reason: >-
Cytosol is the core compartment for AKR1D1, supported by direct assay and
by UniProt.
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
SUBCELLULAR LOCATION: Cytoplasm
- term:
id: GO:0005737
label: cytoplasm
evidence_type: EXP
original_reference_id: PMID:7508385
qualifier: located_in
review:
summary: >-
Experimental localization of AKR1D1 to the cytoplasm from the original
cloning/expression study of the human enzyme.
action: KEEP_AS_NON_CORE
reason: >-
Correct but broader than cytosol; retained as non-core because the more
precise cytosol term is the core compartment.
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
SUBCELLULAR LOCATION: Cytoplasm
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-192033
qualifier: located_in
review:
summary: >-
Reactome traceable-author localization of AKR1D1 to the cytosol for the
bile acid synthesis reduction reactions.
action: ACCEPT
reason: >-
Consistent with the core cytosolic localization of AKR1D1.
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
SUBCELLULAR LOCATION: Cytoplasm
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-192067
qualifier: located_in
review:
summary: >-
Reactome traceable-author localization of AKR1D1 to the cytosol.
action: ACCEPT
reason: >-
Consistent with the core cytosolic localization of AKR1D1.
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
SUBCELLULAR LOCATION: Cytoplasm
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-193746
qualifier: located_in
review:
summary: >-
Reactome traceable-author localization of AKR1D1 to the cytosol.
action: ACCEPT
reason: >-
Consistent with the core cytosolic localization of AKR1D1.
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
SUBCELLULAR LOCATION: Cytoplasm
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-193755
qualifier: located_in
review:
summary: >-
Reactome traceable-author localization of AKR1D1 to the cytosol.
action: ACCEPT
reason: >-
Consistent with the core cytosolic localization of AKR1D1.
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
SUBCELLULAR LOCATION: Cytoplasm
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-193821
qualifier: located_in
review:
summary: >-
Reactome traceable-author localization of AKR1D1 to the cytosol.
action: ACCEPT
reason: >-
Consistent with the core cytosolic localization of AKR1D1.
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
SUBCELLULAR LOCATION: Cytoplasm
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-193824
qualifier: located_in
review:
summary: >-
Reactome traceable-author localization of AKR1D1 to the cytosol.
action: ACCEPT
reason: >-
Consistent with the core cytosolic localization of AKR1D1.
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
SUBCELLULAR LOCATION: Cytoplasm
- term:
id: GO:0005496
label: steroid binding
evidence_type: TAS
original_reference_id: PMID:7508385
qualifier: enables
review:
summary: >-
Steroid binding molecular function, consistent with AKR1D1 binding its
3-oxo-Delta4 steroid substrates in the active site (seen in multiple
substrate co-crystal structures). This binding is part of, and subordinate
to, the catalytic 5-beta-reductase activity.
action: KEEP_AS_NON_CORE
reason: >-
Steroid binding is a genuine molecular property (substrate binding) but is a
component of the catalytic 5-beta-reductase function rather than an
independent core function.
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
C4-C5 double bond of bile acid intermediates and steroid hormones
- term:
id: GO:0005829
label: cytosol
evidence_type: IDA
original_reference_id: PMID:7508385
qualifier: located_in
review:
summary: >-
Direct experimental localization of the human enzyme to the cytosol in the
original cloning/expression study.
action: ACCEPT
reason: >-
Core cytosolic localization, directly supported.
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
SUBCELLULAR LOCATION: Cytoplasm
- term:
id: GO:0006699
label: bile acid biosynthetic process
evidence_type: IDA
original_reference_id: PMID:7508385
qualifier: involved_in
review:
summary: >-
Direct experimental demonstration that the expressed human enzyme has high
5-beta-reductase activity toward the bile acid intermediates
7alpha-hydroxy- and 7alpha,12alpha-dihydroxy-4-cholesten-3-one, and is more
important for bile acid biosynthesis than for steroid hormone metabolism.
This is the core process.
action: ACCEPT
reason: >-
Directly demonstrated core biological process; the expressed enzyme reduces
the key bile acid biosynthetic intermediates.
supported_by:
- reference_id: PMID:7508385
supporting_text: >-
more important for bile acid biosynthesis than for metabolism
- term:
id: GO:0006707
label: cholesterol catabolic process
evidence_type: IDA
original_reference_id: PMID:7508385
qualifier: involved_in
review:
summary: >-
Bile acid biosynthesis is the major route of cholesterol catabolism, so
AKR1D1 is generically associated with cholesterol catabolism. However AKR1D1
does not act on cholesterol itself; it reduces 3-oxo-Delta4 ring
intermediates several steps downstream.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Indirect/downstream framing. AKR1D1's direct substrates are 3-oxo-Delta4
steroid intermediates, not cholesterol. Bile acid biosynthetic process
(GO:0006699) is the precise term for its role.
supported_by:
- reference_id: PMID:7508385
supporting_text: >-
more important for bile acid biosynthesis than for metabolism
- term:
id: GO:0007586
label: digestion
evidence_type: IDA
original_reference_id: PMID:7508385
qualifier: involved_in
review:
summary: >-
Bile acids produced downstream of AKR1D1 aid dietary lipid digestion, so the
enzyme is indirectly linked to digestion. This is a distal physiological
consequence, not a direct function of AKR1D1.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Too indirect. AKR1D1 acts in hepatic bile acid biosynthesis; digestion is a
downstream consequence of bile acids, not an activity of the enzyme.
supported_by:
- reference_id: PMID:7508385
supporting_text: >-
more important for bile acid biosynthesis than for metabolism
- term:
id: GO:0008207
label: C21-steroid hormone metabolic process
evidence_type: IDA
original_reference_id: PMID:7508385
qualifier: involved_in
review:
summary: >-
AKR1D1 can 5-beta-reduce C21 steroid hormones (e.g. cortisol) in vitro. In
the original characterization this activity was small relative to the bile
acid intermediate activity, and the human enzyme is narrower than the rat
enzyme.
action: MARK_AS_OVER_ANNOTATED
reason: >-
A secondary in vitro activity for the human enzyme, subordinate to its core
bile acid biosynthetic role.
supported_by:
- reference_id: PMID:7508385
supporting_text: >-
small but significant 5 beta-reduction
- term:
id: GO:0008209
label: androgen metabolic process
evidence_type: IDA
original_reference_id: PMID:7508385
qualifier: involved_in
review:
summary: >-
AKR1D1 can 5-beta-reduce androgens (e.g. testosterone) in vitro, but in the
original characterization no activity was seen toward androstenedione and
the human enzyme's steroid-hormone activity is narrower than the rat enzyme
and secondary to bile acid biosynthesis.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Peripheral in vitro activity for the human enzyme; not a core process.
supported_by:
- reference_id: PMID:7508385
supporting_text: >-
more important for bile acid biosynthesis than for metabolism
- term:
id: GO:0006699
label: bile acid biosynthetic process
evidence_type: IDA
original_reference_id: PMID:7508385
qualifier: acts_upstream_of_or_within
review:
summary: >-
Direct experimental annotation (MGI) that AKR1D1 acts upstream of or within
bile acid biosynthesis, based on the demonstrated reduction of bile acid
intermediates. Core process.
action: ACCEPT
reason: >-
Core biological process directly supported by the enzyme's demonstrated
reduction of bile acid biosynthetic intermediates.
supported_by:
- reference_id: PMID:7508385
supporting_text: >-
more important for bile acid biosynthesis than for metabolism
core_functions:
- description: >-
NADPH-dependent Delta4-3-oxosteroid 5beta-reductase (EC 1.3.1.3) that reduces
the C4-C5 double bond of 3-oxo-Delta4 steroids to the 5-beta configuration,
forming the cis-fused A/B ring junction. In bile acid biosynthesis it reduces
7alpha-hydroxy- and 7alpha,12alpha-dihydroxy-4-cholesten-3-one to their
5beta-cholestan-3-one products.
molecular_function:
id: GO:0047787
label: Delta4-3-oxosteroid 5beta-reductase activity
directly_involved_in:
- id: GO:0006699
label: bile acid biosynthetic process
locations:
- id: GO:0005829
label: cytosol
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
Catalyzes the stereospecific NADPH-dependent reduction of the
- reference_id: PMID:7508385
supporting_text: >-
more important for bile acid biosynthesis than for metabolism
- description: >-
Broad steroid 5beta-reductase acting on C18-C27 3-oxo-Delta4 steroid hormones
(e.g. testosterone, progesterone, cortisol, cortisone), contributing to
steroid hormone metabolism/catabolism as a cytosolic activity.
molecular_function:
id: GO:0047787
label: Delta4-3-oxosteroid 5beta-reductase activity
directly_involved_in:
- id: GO:0008202
label: steroid metabolic process
locations:
- id: GO:0005829
label: cytosol
supported_by:
- reference_id: file:human/AKR1D1/AKR1D1-uniprot.txt
supporting_text: >-
C4-C5 double bond of bile acid intermediates and steroid hormones
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO
terms
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
vocabulary mapping, accompanied by conservative changes to GO terms applied by
UniProt
findings: []
- id: GO_REF:0000052
title: Gene Ontology annotation based on curation of immunofluorescence data
findings: []
- id: GO_REF:0000116
title: Automatic Gene Ontology annotation based on Rhea mapping
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning models
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:28514442
title: Architecture of the human interactome defines protein communities and disease
networks.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
BioPlex 2.0 proteome-scale AP-MS interactome; source of a bare protein
binding IPI (interactor AKR1C1). Correctly cited but low relevance to
AKR1D1's molecular function.
- id: PMID:33961781
title: Dual proteome-scale networks reveal cell-specific remodeling of the human
interactome.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
BioPlex 3.0 proteome-scale AP-MS interactome; source of a bare protein
binding IPI (interactor AKR1C1). Correctly cited but low relevance to
AKR1D1's molecular function.
- id: PMID:7508385
title: Cloning and expression of cDNA of human delta 4-3-oxosteroid 5 beta-reductase
and substrate specificity of the expressed enzyme.
findings:
- statement: >-
The human enzyme catalyzes NADPH-dependent 5-beta reduction of the Delta4
double bond of bile acid intermediates and steroid hormones, with high
activity toward 7alpha-hydroxy- and 7alpha,12alpha-dihydroxy-4-cholesten-3-one
and only small activity toward steroid hormones; it is more important for
bile acid biosynthesis than for steroid hormone metabolism.
supporting_text: >-
more important for bile acid biosynthesis than for metabolism
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Seminal cloning/expression/characterization paper (abstract only in cache).
Establishes the 5-beta-reductase activity, cytosolic localization, and the
dominant bile acid biosynthetic role. Multiple experimental GOA annotations
trace to it.
- id: Reactome:R-HSA-192033
title: 4-cholesten-7alpha-ol-3-one is reduced to 5beta-cholestan-7alpha-ol-3-one
findings: []
- id: Reactome:R-HSA-192067
title: 4-cholesten-7alpha, 12alpha-diol-3-one is reduced to 5beta-cholesten-7alpha,
12alpha-diol-3-one
findings: []
- id: Reactome:R-HSA-193368
title: Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
findings: []
- id: Reactome:R-HSA-193746
title: 4-cholesten-7alpha,24(S)-diol-3-one is reduced to 5beta-cholestan-7alpha,24(S)-diol-3-one
findings: []
- id: Reactome:R-HSA-193755
title: 'TODO: Fetch title'
findings: []
- id: Reactome:R-HSA-193775
title: Synthesis of bile acids and bile salts via 24-hydroxycholesterol
findings: []
- id: Reactome:R-HSA-193807
title: Synthesis of bile acids and bile salts via 27-hydroxycholesterol
findings: []
- id: Reactome:R-HSA-193821
title: 4-cholesten-7alpha,12alpha,27-triol-3-one is reduced to 5beta-cholestan-7alpha,12alpha,27-triol-3-one
findings: []
- id: Reactome:R-HSA-193824
title: 4-cholesten-7alpha,27-diol-3-one is reduced to 5beta-cholestan-7alpha,27-diol-3-one
findings: []
- id: file:human/AKR1D1/AKR1D1-uniprot.txt
title: UniProtKB entry P51857 (AKR1D1, human) - curated record
findings: []